
1. proc natl acad sci u a. 2009 oct 20;106(42):17945-50. doi:
10.1073/pnas.0907994106. epub 2009 oct 7.

epstein-barr virus lmp2a bypasses p53 inactivation myc model of
lymphomagenesis.

bieging kt(1), amick ac, longnecker r.

author information: 
(1)department microbiology immunology, feinberg school medicine,
northwestern university, chicago, il 60611, usa.

although epstein-barr virus (ebv) linked burkitt's lymphoma (bl), role 
of virus lymphomagenesis unclear. lmp2a, encoded ebv, be
detected bl biopsies prosurvival functions. generated mice
expressing myc lmp2a b cells. lmp2a/lambda-myc mice show greatly
accelerated tumor onset. similar previous work, found p53 mutations in
lambda-myc tumors; however, detected mutations rapidly arising
lmp2a/lambda-myc tumors. demonstrate p53 pathway is
functionally intact lmp2a/lambda-myc tumors, increased levels of
puma sensitivity p53 activation nutlin. work shows lmp2a 
permit tumorigenesis presence intact p53 pathway, identifying an
important contribution ebv bl.

doi: 10.1073/pnas.0907994106 
pmcid: pmc2764894
pmid: 19815507  [indexed medline]

